Fed. Circ. Questions If Safer OxyContin Profits Came From IP

By Dani Kass · October 7, 2024, 9:39 PM EDT

An attorney for Purdue Pharma didn't seem to find much purchase at the Federal Circuit on Monday as he argued that the company's patents for abuse-deterrent OxyContin weren't obvious, claiming other...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Purdue Pharma L.P. v. Accord Healthcare, Inc.

Case Number

23-1953

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

May 30, 2023

Featured Stories

Texas Two-Step Takes Second Step Into Appeals Courts No Photo Available

Rick Archer

The "Texas two-step" will get its second circuit court test Thursday, as a Fourth Circuit panel takes up the question of whether Georg... (more story)

7 Questions For New ABI President Bruce Harwood No Photo Available

Ben Zigterman

Former U.S. Bankruptcy Judge Bruce A. Harwood became the president of the American Bankruptcy Institute last month after retiring in A... (more story)

Toy Industry Braces For Bankruptcies Under Tariffs No Photo Available

Hilary Russ

After Joann Cartiglia started designing dolls from the basement of her home two decades ago, business took off and she began selling t... (more story)